Bonnie Au1,2, Kimberley J Smith2,3, Geneviève Gariépy1,2, Norbert Schmitz1,2,3,4. 1. Department of Epidemiology and Biostatistics, McGill University, Montreal, Quebec, Canada. 2. Douglas Mental Health University Institute, Montreal, Quebec, Canada. 3. Department of Psychiatry, McGill University, Montreal, Quebec, Canada. 4. Montreal Diabetes Research Center, Montreal, Quebec, Canada.
Abstract
OBJECTIVES: The inflammatory marker C-reactive protein (CRP) is associated with depression. We examined the directional relations between CRP and symptoms of depression among older adults. METHOD: The sample consisted of 3397 participants from the English Longitudinal Study of Ageing, a prospective study of community-dwelling older adults. CRP and depressive symptoms were measured at baseline and follow-up. A high CRP level was dichotomized as >3 mg/L. Elevated depressive symptomatology was defined as ≥4 using the 8-item Center for Epidemiologic Studies Depression Scale. Logistic regressions computed the association between high CRP levels at baseline with elevated depressive symptoms at follow-up, and vice versa. RESULTS: After adjusting for baseline depressive symptoms, baseline high CRP levels were associated with subsequent elevated symptoms of depression (OR = 1.49; 95% CI, 1.19-1.88). This relationship was no longer significant after simultaneous adjustments for metabolic and health variables. In the other direction, after adjusting for baseline CRP levels, baseline elevated depressive symptoms was not associated with subsequent high CRP levels (OR = 1.12; 95% CI, 0.88-1.42). CONCLUSION: High CRP levels at baseline are related to elevated depressive symptomatology at follow-up due to clinical factors. No association was found in the opposite direction.
OBJECTIVES: The inflammatory marker C-reactive protein (CRP) is associated with depression. We examined the directional relations between CRP and symptoms of depression among older adults. METHOD: The sample consisted of 3397 participants from the English Longitudinal Study of Ageing, a prospective study of community-dwelling older adults. CRP and depressive symptoms were measured at baseline and follow-up. A high CRP level was dichotomized as >3 mg/L. Elevated depressive symptomatology was defined as ≥4 using the 8-item Center for Epidemiologic Studies Depression Scale. Logistic regressions computed the association between high CRP levels at baseline with elevated depressive symptoms at follow-up, and vice versa. RESULTS: After adjusting for baseline depressive symptoms, baseline high CRP levels were associated with subsequent elevated symptoms of depression (OR = 1.49; 95% CI, 1.19-1.88). This relationship was no longer significant after simultaneous adjustments for metabolic and health variables. In the other direction, after adjusting for baseline CRP levels, baseline elevated depressive symptoms was not associated with subsequent high CRP levels (OR = 1.12; 95% CI, 0.88-1.42). CONCLUSION: High CRP levels at baseline are related to elevated depressive symptomatology at follow-up due to clinical factors. No association was found in the opposite direction.
Authors: Maria Carmen Viana; Carmen C W Lim; Flavia Garcia Pereira; Sergio Aguilar-Gaxiola; Jordi Alonso; Ronny Bruffaerts; Peter de Jonge; Jose Miguel Caldas-de-Almeida; Siobhan O'Neill; Dan J Stein; Ali Al-Hamzawi; Corina Benjet; Graça Cardoso; Silvia Florescu; Giovanni de Girolamo; Josep Maria Haro; Chiyi Hu; Viviane Kovess-Masfety; Daphna Levinson; Marina Piazza; José Posada-Villa; Daniel Rabczenko; Ronald C Kessler; Kate M Scott Journal: J Pain Date: 2017-10-12 Impact factor: 5.820
Authors: Naoise Mac Giollabhui; Dominika Swistun; Susan Murray; Daniel P Moriarity; Marin M Kautz; Lauren M Ellman; Thomas M Olino; Christopher L Coe; Lyn Y Abramson; Lauren B Alloy Journal: Psychol Med Date: 2019-03-28 Impact factor: 7.723
Authors: Ezgi Dogan-Sander; Roland Mergl; Anja Willenberg; Ronny Baber; Kerstin Wirkner; Steffi G Riedel-Heller; Susanne Röhr; Frank M Schmidt; Georg Schomerus; Christian Sander Journal: Nutrients Date: 2021-06-08 Impact factor: 5.717